Table 3.
Multivariate logistic analysis for Severe SARS-CoV-2 and secondary outcomes.
| Outcome Variable |
Adjusted Odds ratio (95% confidence interval) |
|||
|---|---|---|---|---|
| Severe SARS-CoV-2 (n = 64) | ICU admission (n = 49) | MV (n = 27) | Mortality (n = 13) | |
| Age | 1.02 (0.99–1.06) | 0.99 (0.95–1.02) | 0.99 (0.95–1.04) | 1.07 (0.98–1.16) |
| AI/IMID | 0.28 (0.12–0.61)* | 0.25 (0.10–0.62)* | 0.20 (0.05–0.71)* | 0.75 (0.18–3.16) |
| Hypertension | 1.77 (0.80–3.94) | 1.48 (0.63–3.49) | 2.92 (0.99–8.57) | 8.67 (0.93–80.64) |
| CHD | 1.64 (0.66–4.02) | |||
| Dyslipidemia | 1.58 (0.70–3.57) | 1.33 (0.50–3.55) | 1.41 (0.37–5.42) | |
| COPD | 1.78 (0.57–5.51) | 1.34 (0.38–4.73) | ||
| Diabetes | 1.25 (0.33–4.74) | |||
*P < 0.005.
AI/IMID: autoimmune or immune-mediated inflammatory disease; CHD: chronic heart disease; COPD: chronic obstructive pulmonary disease; GC: glucocorticoids; ICU: intensive care unit; MV: mechanical ventilation.